Occurrence of pituitary deficiency
| Hormone deficiencies | Baseline | 6 months’ follow-up | 14 months’ follow-up | |||
|---|---|---|---|---|---|---|
| N (%) | m/f ratio | N (%) | m/f ratio | N (%) | m/f ratio | |
| Any deficiency | 37 (44%) | 10/27 | 22 (26%) | 10/12 | 6 (7%) | 5/1 |
| GH deficiency | 26 (31%) | 7/19 | 8 (10%) | 7/1* | 5 (6%) | 5/0* |
| Gonadotropin deficiency | 29 (34%) | 10/19 | 17 (20%) | 5/12 | 4 (5%) | 3/1 |
| ACTH deficiency | 1 (1%) | 0/1 | – | – | – | – |
| TSH deficiency | 1 (1%) | 0/1 | – | – | – | – |
Number (%) of deficient pituitary axes and male/female ratio of deficient patients at baseline, 6 and 14 months after SAH.
*p<0.001; OR:17.8 after 6 months.
ACTH, adrenocorticotropic releasing hormone; GH, growth hormone; SAH, subarachnoid haemorrhage; TSH, thyroid stimulating hormone.